Taku Nakaoka Named CEO of Upsher-Smith Laboratories
Senior Vice President of Corporate Strategy, Rich Fisher, to Assume Day-to-Day Leadership as President & COO.
As Chairman and CEO, Mr. Nakaoka is responsible for the strategic direction, operating performance and growth of Upsher-Smith. Mr. Nakaoka also serves as Corporate Officer and Group Chief Officer of Corporate Strategy of Sawai Group Holdings Co., Ltd., Upsher-Smith's parent company, and Corporate Officer and General Manager of Corporate Strategy at Sawai Pharmaceutical Co., Ltd. Prior to Sawai, he held several executive-level positions at Sumitomo Corporation.
"I am honored to assume this role as Chairman and CEO and look forward to working alongside the executive team to drive the strategic direction of the company, expand global partnerships and enhance programs critical to future growth," said Taku Nakaoka, Chairman and CEO of Upsher-Smith. "Rusty's strong and determined leadership over the past eight years was integral to building a strong foundation for Upsher-Smith and Rich Fisher's previous role as Senior Vice President of Corporate Strategy makes him well-positioned to successfully lead the company as President and COO."
About Upsher-Smith
Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that strives to improve the health and lives of patients through an unwavering commitment to high-quality products and sustainable growth. The company brings brands and generics to a wide array of customers, always backed by its attentive level of service, strong industry relationships, and dedication to uninterrupted supply. For more information, visit
SOURCE Upsher-Smith Laboratories, LLC
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- NCPA Announces Keynote Speaker for Annual Convention
September 18th 2025
- Upcoming NCPA Items for Pharmacy Teams: September and October 2025
September 11th 2025
- NCPA Applauds FTC Pick for Associate Director of Health Care
September 10th 2025
- NCPA Leads Huge Coalition in Letter Asking Congress to Pass PBM Reform Act
September 8th 2025